免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

Glidewire GT-R

K 號:K240859 · 2024-08-21

決定日期2024-08-21
產品代碼DQX
諮詢委員會履歷
決定相當於

器材摘要

Glidewire GT-R is the device name listed in this FDA 510(k) record. The listed applicant is Terumo Corporation. It received FDA 510(k) clearance on 2024-08-21 under 510(k) number K240859. The device is classified under product code DQX. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Glidewire GT-R?

Glidewire GT-R is a medical device that received FDA 510(k) clearance on 2024-08-21. The listed applicant is Terumo Corporation. The 510(k) number is K240859.

When did Glidewire GT-R receive FDA 510(k) clearance?

Glidewire GT-R received FDA 510(k) clearance on 2024-08-21, under 510(k) number K240859.

Who is the listed applicant for Glidewire GT-R?

The FDA 510(k) record lists Terumo Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Glidewire GT-R?

The FDA product code for Glidewire GT-R is DQX.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Terumo Corporation 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 9 項裝置 →

相關器械(代碼:DQX)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑